Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Geron Corporation
< Previous
1
2
3
4
5
Next >
Geron to Present at the 21st Annual Needham Virtual Healthcare Conference
April 06, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants
April 01, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants
March 30, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants
March 29, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 17, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference
January 21, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at the H.C. Wainwright BioConnect Conference
January 04, 2022
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 16, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Presentations at American Society of Hematology Annual Meeting
December 14, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Appointment of Chief Business Officer
December 02, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 18, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Present at the Stifel 2021 Virtual Healthcare Conference
November 12, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Presents Investor Event Highlights
November 09, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting
November 04, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Enters New Innovative Licensing and Access Pathway in the United Kingdom for Imetelstat
October 25, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 21, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
October 18, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Host a Virtual Investor Event in November
October 15, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
October 11, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 16, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces September Investor Conference Presentation Webcasts
September 01, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 19, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Reports Greater Than 90% Enrollment in IMerge Phase 3 and Expected Top-Line Results Accelerated to First Quarter of 2023
August 16, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron to Announce Second Quarter 2021 Financial Results on August 16, 2021
August 05, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 22, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology
June 17, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress
June 14, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress
May 12, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights
May 10, 2021
From
Geron Corporation
Via
Business Wire
Tickers
GERN
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.